This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Tel Aviv University. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Lilach Vaks: Innovator in Antibody Technology
Introduction
Lilach Vaks is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of antibody technology, holding 2 patents that showcase her innovative approach to biopharmaceuticals. Her work focuses on the development of bi- and monospecific, asymmetric antibodies, which have important applications in therapeutic treatments.
Latest Patents
Lilach's latest patents include groundbreaking methods for generating antibodies. One of her notable inventions involves an antibody that comprises an Fc region and a Fab region. The Fab region features a first covalent link between a first heavy chain and a first light chain, as well as a second covalent link between a second heavy chain and a second light chain. The unique positioning of these covalent links relative to their respective heavy chains distinguishes her work in the field. These methods and their uses are crucial for advancing antibody-based therapies.
Career Highlights
Lilach Vaks is affiliated with Tel Aviv University, where she continues to push the boundaries of research in antibody technology. Her academic background and research endeavors have positioned her as a leading figure in her field.
Collaborations
Lilach has collaborated with notable colleagues, including Itai Benhar, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Lilach Vaks is a trailblazer in the development of innovative antibody technologies. Her contributions are paving the way for advancements in therapeutic applications, making her a key figure in the scientific community.